Loading interface...

Rup-AL 10 mg Tablet

Manufactured byHETERO HEALTHCARE LTD
ContainsRupatadine
Description
Rup-AL 10 mg Tablet is an effective anti-allergic medicine used to temporarily relieve the symptoms of seasonal allergies. These symptoms may include sneezing, runny nose, itchy eyes, sore throat, etc. This medicine is not recommended for use in children below 12 years of age.

Substitutes

List of substitutes for Rup-AL 10 mg Tablet

Rupiz 10 mg Tablet
Zydus Cadila
Smarti 10 mg Tablet
Zydus Cadila

Side effects

Major & minor side effects for Rup-AL 10 mg Tablet

  • Headache
  • Dizziness
  • Dry mouth
  • Fatigue
  • Tiredness and weakness
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Vomiting
  • Constipation
  • Rash

Uses of Rup-AL 10 mg Tablet

What is it prescribed for?

  • Allergic Rhinitis
  • Urticaria
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to rupatadine or any other inactive ingredients present along with this medicine.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
General warnings

Use in elderly patients

This medicine should be used with caution in elderly patients (age > 65 years) due to the increased risk of severe adverse effects. Close monitoring of such patients for any adverse effects may be required in some cases. Replacement with a suitable alternative may be necessary based on the clinical condition.

Use in pediatrics

This medicine is not recommended for use in patients below 12 years of age since the safety and efficacy of use are not clinically established.

QT prolongation

This medicine should be used with caution in patients with a prolonged QT interval due to the increased risk of worsening of the patient's condition. Close monitoring of such patients for any changes in QT interval may be necessary. Replacement with a suitable alternative may be required based on the clinical condition.

Driving or Operating machines

Use of this medicine may cause drowsiness or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Renal impairment

This medicine is not recommended for use in patients with a known history of renal diseases since the safety and efficacy of use are not clinically established for such patients.

Hepatic impairment

This medicine is not recommended for use in patients with a known history of liver diseases since the safety and efficacy of use are not clinically established for such patients.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

CYP3A4 inhibitors

Erythromycin

Ketoconazole

Disease interactions

Disease

Information not available.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Lab interactions
Information not available.
Take this medicine with or without food. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by reducing a chemical substance called histamine, which is responsible for causing allergic symptoms.
Legal Status

Approved

Unknown

Approved

Approved

Classification

Category

Antihistamines

Schedule

Schedule H

Rupatadine - DrugBank [Internet]. Drugbank.ca. 2018 [cited 23 March 2018]. Available from:

https://www.drugbank.ca/drugs/DB11614

[Internet]. 2018 [cited 23 March 2018]. Available from:

https://www2.medicines.org.uk/emc/medicine/33172

[Internet]. 2018 [cited 23 March 2018]. Available from:

https://www2.medicines.org.uk/emc/PIL.33171.latest.pdf

[Internet]. Pedia-pharm.com. 2018 [cited 23 March 2018]. Available from:

http://www.pedia-pharm.com/en/wp-content/uploads/sites/3/2017/02/RUPALL-monograph-EN.pdf

[Internet]. Shijiebiaopin.net. 2018 [cited 23 March 2018]. Available from:

http://www.shijiebiaopin.net/upload/product/201221319054711.PDF
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 26 Mar 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.